Annual ROE
-10.83%
-14.58%-388.80%
31 December 2023
Summary:
Arcturus Therapeutics Holdings annual return on equity is currently -10.83%, with the most recent change of -14.58% (-388.80%) on 31 December 2023. During the last 3 years, it has risen by +23.34% (+68.31%). ARCT annual ROE is now -103.89% below its all-time high of 278.48%, reached on 31 December 2012.ARCT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-23.32%
+3.01%+11.43%
30 September 2024
Summary:
Arcturus Therapeutics Holdings quarterly return on equity is currently -23.32%, with the most recent change of +3.01% (+11.43%) on 30 September 2024. Over the past year, it has dropped by -61.22% (-161.53%). ARCT quarterly ROE is now -109.48% below its all-time high of 246.03%, reached on 31 March 2013.ARCT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARCT ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -388.8% | -161.5% |
| 3 y3 years | +68.3% | +62.5% |
| 5 y5 years | +88.2% | +73.3% |
ARCT ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -388.8% | +83.4% | -146.1% | +68.7% |
| 5 y | 5 years | -388.8% | +91.8% | -146.1% | +82.8% |
| alltime | all time | -103.9% | +97.3% | -109.5% | +82.8% |
Arcturus Therapeutics Holdings ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -23.32%(-11.4%) |
| June 2024 | - | -26.33%(-29.5%) |
| Mar 2024 | - | -37.33%(+262.4%) |
| Dec 2023 | -10.83%(-388.8%) | -10.30%(-127.2%) |
| Sept 2023 | - | 37.90%(+13.4%) |
| June 2023 | - | 33.42%(-33.9%) |
| Mar 2023 | - | 50.55%(+980.1%) |
| Dec 2022 | 3.75%(-105.8%) | 4.68%(-106.3%) |
| Sept 2022 | - | -74.19%(+3.0%) |
| June 2022 | - | -72.04%(-3.4%) |
| Mar 2022 | - | -74.60%(+13.0%) |
| Dec 2021 | -65.20%(+90.8%) | -66.04%(+6.1%) |
| Sept 2021 | - | -62.24%(+7.6%) |
| June 2021 | - | -57.82%(+9.2%) |
| Mar 2021 | - | -52.94%(+16.6%) |
| Dec 2020 | -34.17%(-74.1%) | -45.41%(-24.3%) |
| Sept 2020 | - | -59.98%(-39.6%) |
| June 2020 | - | -99.28%(-26.7%) |
| Mar 2020 | - | -135.43%(+7.7%) |
| Dec 2019 | -131.82%(+43.5%) | -125.80%(+44.0%) |
| Sept 2019 | - | -87.35%(+0.1%) |
| June 2019 | - | -87.23%(-32.3%) |
| Mar 2019 | - | -128.87%(+39.2%) |
| Dec 2018 | -91.85% | -92.57%(+2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | -90.01%(+26.0%) |
| June 2018 | - | -71.45%(+66.6%) |
| Mar 2018 | - | -42.90%(+4.1%) |
| Dec 2017 | -61.64%(+1291.4%) | -41.23%(-257.1%) |
| Sept 2017 | - | 26.24%(+122.9%) |
| June 2017 | - | 11.77%(<-9900.0%) |
| Mar 2017 | - | -0.01%(-99.7%) |
| Dec 2016 | -4.43%(+4.0%) | -3.16%(-70.4%) |
| Sept 2016 | - | -10.67%(+147.0%) |
| June 2016 | - | -4.32%(+24.1%) |
| Mar 2016 | - | -3.48%(-12.8%) |
| Dec 2015 | -4.26%(-97.4%) | -3.99%(-94.2%) |
| Sept 2015 | - | -68.34%(-30.1%) |
| June 2015 | - | -97.76%(-12.4%) |
| Mar 2015 | - | -111.58%(+5.0%) |
| Dec 2014 | -164.64%(+660.1%) | -106.28%(+27.5%) |
| Sept 2014 | - | -83.34%(+23.8%) |
| June 2014 | - | -67.30%(+22.7%) |
| Mar 2014 | - | -54.84%(+53.5%) |
| Dec 2013 | -21.66%(-107.8%) | -35.73%(-8.9%) |
| Sept 2013 | - | -39.21%(+77.7%) |
| June 2013 | - | -22.06%(-109.0%) |
| Mar 2013 | - | 246.03%(+37.0%) |
| Dec 2012 | 278.48%(-169.8%) | 179.54% |
| Dec 2011 | -398.88% | - |
FAQ
- What is Arcturus Therapeutics Holdings annual return on equity?
- What is the all time high annual ROE for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual ROE year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly return on equity?
- What is the all time high quarterly ROE for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly ROE year-on-year change?
What is Arcturus Therapeutics Holdings annual return on equity?
The current annual ROE of ARCT is -10.83%
What is the all time high annual ROE for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual return on equity is 278.48%
What is Arcturus Therapeutics Holdings annual ROE year-on-year change?
Over the past year, ARCT annual return on equity has changed by -14.58% (-388.80%)
What is Arcturus Therapeutics Holdings quarterly return on equity?
The current quarterly ROE of ARCT is -23.32%
What is the all time high quarterly ROE for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly return on equity is 246.03%
What is Arcturus Therapeutics Holdings quarterly ROE year-on-year change?
Over the past year, ARCT quarterly return on equity has changed by -61.22% (-161.53%)